Results 21 to 30 of about 74,900 (265)

Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis

Clinics, 2014
OBJECTIVES:This study aimed to investigate the clinical correlation between angiographic coronary atherosclerosis and N-terminal pro-B-type natriuretic peptide along with other known correlated factors.METHODS:In total, 153 patients with a diagnostic ...
Demóstenes G.L. Ribeiro, Ricardo P. Silva, Daniella R.M.M. Barboza, Roberto C.P. Lima-Júnior, Ronaldo A. Ribeiro   +4 more
doaj   +1 more source

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide

Diagnostics, 2023
BACKGROUND: The B-type natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (pBNP) are predictors of cardiovascular morbidity and mortality. Since the artificial intelligence (AI)-enabled electrocardiogram (ECG) system is widely used in
Pang-Yen Liu, Chin Lin, Chin-Sheng Lin, Wen-Hui Fang, Chia-Cheng Lee, Chih-Hung Wang, Dung-Jang Tsai   +6 more
doaj   +1 more source

Application of B-Type Natriuretic Peptide in Neonatal Diseases

Frontiers in Pediatrics, 2021
Numerous congenital or secondary diseases, including, heart disease, respiratory disease, sepsis and many others, can lead to neonatal death. B-type natriuretic peptide (BNP) is a peptide hormone secreted by ventricular cells following an increase in ...
Haotai Xie, Yixuan Huo, Qinzheng Chen, Xinlin Hou   +3 more
doaj   +1 more source

Ischemic Stroke in Acute Decompensated Heart Failure: From the KCHF Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Heart failure (HF) is a known risk factor for ischemic stroke, but data regarding ischemic stroke during hospitalization for acute decompensated HF (ADHF) are limited. Methods and Results We analyzed the data from a multicenter registry (Kyoto
Moritake Iguchi, Takao Kato, Hidenori Yaku, Takeshi Morimoto, Yasutaka Inuzuka, Yodo Tamaki, Neiko Ozasa, Erika Yamamoto, Yusuke Yoshikawa, Takeshi Kitai, Yasuhiro Hamatani, Yugo Yamashita, Nobutoyo Masunaga, Hisashi Ogawa, Mitsuru Ishii, Yoshimori An, Ryoji Taniguchi, Masashi Kato, Mamoru Takahashi, Toshikazu Jinnai, Tomoyuki Ikeda, Kazuya Nagao, Takafumi Kawai, Akihiro Komasa, Ryusuke Nishikawa, Yuichi Kawase, Takashi Morinaga, Mitsunori Kawato, Yuta Seko, Mamoru Toyofuku, Yutaka Furukawa, Kenji Ando, Kazushige Kadota, Mitsuru Abe, Masaharu Akao, Yukihito Sato, Koichiro Kuwahara, Takeshi Kimura   +37 more
doaj   +1 more source

Short-term add-on therapy with angiotensin receptor blocker for end-stage inotrope-dependent heart failure patients: B-type natriuretic peptide reduction in a randomized clinical trial

Clinics, 2014
OBJECTIVE: We aimed to evaluate angiotensin receptor blocker add-on therapy in patients with low cardiac output during decompensated heart failure.
Marcelo E. Ochiai, Euler C.O. Brancalhão, Raphael S. N. Puig, Kelly R.N. Vieira, Juliano N. Cardoso, Múcio Tavares de Oliveira-Jr, Antonio C.P. Barretto   +6 more
doaj   +1 more source

ANP and BNP responses to dehydration in the one-humped camel and effects of blocking the renin-angiotensin system. [PDF]

PLoS ONE, 2013
The objectives of this study were to investigate and compare the responses of atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) in the circulation of hydrated, dehydrated, and dehydrated losartan - treated camels; and to document the ...
Abdu Adem, Mahmoud Al Haj, Sheela Benedict, Javed Yasin, Nicolas Nagelkerke, Fred Nyberg, Tim G Yandle, Chris M Frampton, Lynley K Lewis, M Gary Nicholls, Elsadig Kazzam   +10 more
doaj   +1 more source

B‐Type Natriuretic Peptide: A Critical Review [PDF]

Congestive Heart Failure, 2007
Natriuretic peptides have been used as tools for diagnosis and risk stratification in patients with heart failure, myocardial infarction, and unstable coronary syndromes, as well as in the general population. The biology of intra‐assay and intraindividual variations of plasma natriuretic peptide levels is still not clearly understood despite their ...
openaire   +2 more sources

B‐type natriuretic peptide and severity of cognitive disorder [PDF]

European Journal of Clinical Investigation, 2013
AbstractBackgroundNatriuretic peptides have been linked to cognitive disorder in previous studies. The aim of this study was to examine the association between the severity of cognitive disorder and the levels of B‐type natriuretic peptide (BNP) in an older general population.Material and methodsThis study is a part of the larger population‐based ...
Sulkava Raimo, Hartikainen Sirpa, Hiltunen Matti, Nieminen Tuomo, Sulkava Raimo, Hartikainen Sirpa, Hiltunen Matti, Nieminen Tuomo, Kettunen Raimo, Kerola Tuomas, Nieminen Tuomo   +10 more
openaire   +2 more sources

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

Arthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source

B-Type Natriuretic Peptide as a Predictor of Short-Term Mortality in On-Pump Coronary Artery Bypass Grafting

Brazilian Journal of Cardiovascular Surgery
Objective: The present study refers to a determination of the preoperative B-type natriuretic peptide is a predictor of short-term all-cause mortality in patients undergoing on-pump coronary artery bypass graft surgeries. Methods: Two hundred and twenty-
Jamil Alli Murad Junior, Maurício Nassau Machado, Marcio Pimentel Fernandes, Marcelo José Ferreira Soares, Ingrid Helen Grigolo, Cristiane Carvalho Singulane, Moacir Fernandes de Godoy   +6 more
doaj   +1 more source